Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hyperinsulinism D006946 27 associated lipids
Brain Diseases D001927 27 associated lipids
Gastritis D005756 27 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Neuralgia D009437 28 associated lipids
Vitamin E Deficiency D014811 29 associated lipids
Endometrial Neoplasms D016889 30 associated lipids
Proteinuria D011507 30 associated lipids
Cardiomegaly D006332 31 associated lipids
Hypertension, Pulmonary D006976 32 associated lipids
Stroke D020521 32 associated lipids
Neurodegenerative Diseases D019636 32 associated lipids
Thyroid Neoplasms D013964 33 associated lipids
Memory Disorders D008569 33 associated lipids
Acute Lung Injury D055371 33 associated lipids
Uremia D014511 33 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Burns D002056 34 associated lipids
Acute Kidney Injury D058186 34 associated lipids
Spinal Cord Injuries D013119 34 associated lipids
Fever D005334 35 associated lipids
Glomerulonephritis D005921 35 associated lipids
Anaphylaxis D000707 35 associated lipids
Epilepsy D004827 35 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Liver Cirrhosis, Experimental D008106 36 associated lipids
Nervous System Diseases D009422 37 associated lipids
Lung Diseases D008171 37 associated lipids
Peritonitis D010538 38 associated lipids
Diabetic Retinopathy D003930 39 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Hypotension D007022 41 associated lipids
Leukemia, Erythroblastic, Acute D004915 41 associated lipids
Arthritis D001168 41 associated lipids
Leukemia, Experimental D007942 42 associated lipids
Ischemic Attack, Transient D002546 42 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Hyperalgesia D006930 42 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Hypersensitivity, Delayed D006968 43 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Psoriasis D011565 47 associated lipids
Thrombosis D013927 49 associated lipids
Osteosarcoma D012516 50 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kono N et al. Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo. 2008 J. Biol. Chem. pmid:18024956
Steel HC et al. Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure. 2008 Chem Biol Drug Des pmid:18924285
Penna C et al. The platelet activating factor triggers preconditioning-like cardioprotective effect via mitochondrial K-ATP channels and redox-sensible signaling. 2008 J. Physiol. Pharmacol. pmid:18441387
Bang UC et al. Pharmacological approach to acute pancreatitis. 2008 World J. Gastroenterol. pmid:18494044
Bélanger C et al. Involvement of endogenous leukotriene B4 and platelet-activating factor in polymorphonuclear leucocyte recruitment to dermal inflammatory sites in rats. 2008 Immunology pmid:18217950
Zheng HL et al. [Role of platelet-activating factor in progesterone synthesis and vascular endothelial growth factor expression in rat luteal cells]. 2008 Sheng Li Xue Bao pmid:18425318
Di Y et al. [Effect of ginkgolide B on plasma levels of interleukin-12 and PAF in severe acute pancreatitis in rats]. 2008 Zhongguo Ying Yong Sheng Li Xue Za Zhi pmid:21141514
Ogura M et al. Platelet-activating factor (PAF) induced cytokine production and otitis media with effusion (OME) in the rat middle ear. 2008 Auris Nasus Larynx pmid:17997066
Figueiredo MB et al. Blockades of phospholipase A(2) and platelet-activating factor receptors reduce the hemocyte phagocytosis in Rhodnius prolixus: in vitro experiments. 2008 J. Insect Physiol. pmid:18036540
Rastogi P et al. Tryptase activates calcium-independent phospholipase A2 and releases PGE2 in airway epithelial cells. 2008 Am. J. Physiol. Lung Cell Mol. Physiol. pmid:18790994
Belayev L et al. LAU-0901, a novel platelet-activating factor antagonist, is highly neuroprotective in cerebral ischemia. 2008 Exp. Neurol. pmid:18793637
Chu W et al. Flavonoids from Chinese Viscum coloratum produce cytoprotective effects against ischemic myocardial injuries: inhibitory effect of flavonoids on PAF-induced Ca2+ overload. 2008 Phytother Res pmid:17724771
Morita K et al. Glycinergic mediation of tactile allodynia induced by platelet-activating factor (PAF) through glutamate-NO-cyclic GMP signalling in spinal cord in mice. 2008 Pain pmid:18353555
Simonenko VB et al. [Losartan for the correction of thrombocyte activity in patients suffering from arterial hypertension with metabolic syndrome]. 2008 Klin Med (Mosk) pmid:18326282
Kudriavtseva IuA et al. [Sorption and contact-activating properties of the <biograft-artery> anastomosis zone: effect of suture material (communication II)]. 2008 Angiol Sosud Khir pmid:19156039
Ibe BO et al. Mechanisms by which S-albuterol induces human bronchial smooth muscle cell proliferation. 2008 Int. Arch. Allergy Immunol. pmid:18362475
Tiemann U The role of platelet-activating factor in the mammalian female reproductive tract. 2008 Reprod. Domest. Anim. pmid:18363604
Ibe BO et al. Platelet-activating factor stimulates ovine foetal pulmonary vascular smooth muscle cell proliferation: role of nuclear factor-kappa B and cyclin-dependent kinases. 2008 Cell Prolif. pmid:18336468
Lu J et al. Polyunsaturated fatty acids block platelet-activating factor-induced phosphatidylinositol 3 kinase/Akt-mediated apoptosis in intestinal epithelial cells. 2008 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:18356536
Tsoukatos DC et al. Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery. 2008 J. Lipid Res. pmid:18587071
Ryan SD et al. Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons. 2008 J. Lipid Res. pmid:18550892
Jiang Y et al. Three-dimensional localization and quantification of PAF-induced gap formation in intact venular microvessels. 2008 Am. J. Physiol. Heart Circ. Physiol. pmid:18515648
LeBlanc CJ et al. Effects of dietary supplementation with fish oil on in vivo production of inflammatory mediators in clinically normal dogs. 2008 Am. J. Vet. Res. pmid:18380580
Su J et al. Natural antibodies against phosphorylcholine as potential protective factors in SLE. 2008 Rheumatology (Oxford) pmid:18522961
McLaughlin NJ et al. Platelet-activating factor-mediated endosome formation causes membrane translocation of p67phox and p40phox that requires recruitment and activation of p38 MAPK, Rab5a, and phosphatidylinositol 3-kinase in human neutrophils. 2008 J. Immunol. pmid:18523285
Landgraf RG et al. Prostaglandins, leukotrienes and PAF selectively modulate lymphocyte subset and eosinophil infiltration into the airways in a murine model of asthma. 2007 Oct-Nov Prostaglandins Leukot. Essent. Fatty Acids pmid:17923399
Vadnais ML et al. Current concepts of molecular events during bovine and porcine spermatozoa capacitation. 2007 May-Jun Arch. Androl. pmid:17612869
Rosenwasser L New insights into the pathophysiology of allergic rhinitis. 2007 Jan-Feb Allergy Asthma Proc pmid:17390750
De Vriese C et al. Ghrelin interacts with human plasma lipoproteins. 2007 Endocrinology pmid:17289852
Liu WC et al. Lipopolysaccharide-induced cerebral inflammatory damage and the therapeutic effect of platelet activating factor receptor antagonist. 2007 Neurosci Bull pmid:17952135
Wu B et al. [Effects of bificobacterium longum on neonatal rat model of necrotizing enterocolitis and roles of platelet-activating factor and tumor necrosis factor-alpha]. 2007 Zhonghua Er Ke Za Zhi pmid:17953818
Owen JS et al. Platelet-activating factor. 2007 Meth. Enzymol. pmid:17954244
Ying-fang S et al. Effect of platelet-activating factor on cell proliferation & NF-kappaB activation in airway smooth muscle cells in rats. 2007 Indian J. Med. Res. pmid:17932440
Guerra CT et al. Effect of chronic hepatitis C virus infection on inflammatory lipid mediators. 2007 Dig Liver Dis pmid:17936229
Ebihara S et al. A simple preparation method for mouse eosinophils and their responses to anti-allergic drugs. 2007 Inflamm. Res. pmid:17406808
Slomiany BL and Slomiany A Interference by leptin with Helicobacter pylori lipopolysaccharide-induced cytosolic phospholipase A2 activation in gastric mucosal cells. 2007 J. Physiol. Pharmacol. pmid:17440231
Ullrich SE Sunlight and skin cancer: lessons from the immune system. 2007 Mol. Carcinog. pmid:17443748
Richter M et al. Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in mice. 2007 Prostaglandins Leukot. Essent. Fatty Acids pmid:17448648
Finnegan EM et al. Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion. 2007 Am. J. Physiol. Heart Circ. Physiol. pmid:17483236
Cattaneo M et al. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. 2007 Haematologica pmid:17488697
Kälvegren H et al. Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors. 2007 Eur. J. Pharmacol. pmid:17459368
Rockel N et al. The osmolyte taurine protects against ultraviolet B radiation-induced immunosuppression. 2007 J. Immunol. pmid:17785795
Bathgate R et al. Effects of platelet-activating factor and platelet-activating factor: acetylhydrolase on in vitro post-thaw boar sperm parameters. 2007 Theriogenology pmid:17157372
Hammond A et al. Platelets in equine recurrent airway obstruction. 2007 Res. Vet. Sci. pmid:17107696
Vinores SA et al. TNF-alpha is critical for ischemia-induced leukostasis, but not retinal neovascularization nor VEGF-induced leakage. 2007 J. Neuroimmunol. pmid:17107717
Brkovic A and Sirois MG Vascular permeability induced by VEGF family members in vivo: role of endogenous PAF and NO synthesis. 2007 J. Cell. Biochem. pmid:17115409
Choi JH et al. Impairment of p38 MAPK-mediated cytosolic phospholipase A2 activation in the kidneys is associated with pathogenicity of Candida albicans. 2007 Immunology pmid:17054728
Park EJ et al. Dietary ganglioside inhibits acute inflammatory signals in intestinal mucosa and blood induced by systemic inflammation of Escherichia coli lipopolysaccharide. 2007 Shock pmid:17510604
Young RE et al. Role of neutrophil elastase in LTB4-induced neutrophil transmigration in vivo assessed with a specific inhibitor and neutrophil elastase deficient mice. 2007 Br. J. Pharmacol. pmid:17471175
Steel HC et al. Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4. 2007 Clin. Exp. Immunol. pmid:17683509